
Study Finds Different Outcomes for Anti-Clotting Medications in Diabetic Patients After Stent Placement
New research presented at the American Heart Association's Scientific Sessions 2025 suggests prasugrel may offer better outcomes than ticagrelor for diabetic patients with stents, challenging current interchangeable use of these antiplatelet medications.
Read full story























